Vimta Labs Ltd. (VIMTALABS)
Market Closed
10 Aug, 10:00
XNSE XNSE Primary MSE ₹
645. 65
-5.6
-0.8599%
₹
18.99B Market Cap
27.73 P/E Ratio
1% Div Yield
112,751 Volume
0 Eps
₹ 651.25
Previous Close Want to track VIMTALABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
VIMTALABS closed today lower at ₹645.65, a decrease of -0.8599% from yesterday's close, completing a monthly increase of 10.3675% or ₹60.65. Over the past 12 months, VIMTALABS stock gained 6.6661%.
VIMTALABS pays dividends to its shareholders, with the most recent payment made on Jul 08, 2026. The next estimated payment will be in In 10 months on Jul 08, 2027 for a total of ₹2.
The last earnings report, released on May 30, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Vimta Labs Ltd. has completed 2 stock splits, with the recent split occurring on Jun 13, 2025.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
Vimta Labs Ltd. (VIMTALABS) FAQ
What is the stock price today?
The current price is ₹645.65.
On which exchange is it traded?
Vimta Labs Ltd. is listed on XNSE.
What is its stock symbol?
The ticker symbol is VIMTALABS.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1%.
What is its market cap?
As of today, the market cap is 18.99B.
Has Vimta Labs Ltd. ever had a stock split?
Vimta Labs Ltd. had 2 splits and the recent split was on Jun 13, 2025.
Vimta Labs Ltd. Profile
| Professional Services Industry | Industrials Sector | Dr. Sivalinga Prasad Vasireddi CEO | XNSE Exchange | Y9376C129 CUSIP |
| India Country | 1,315 Employees | 18 Jun 2026 Last Dividend | 13 Jun 2025 Last Split | - IPO Date |
Overview
Vimta Labs Limited, established in 1984 and based in Hyderabad, India, operates as a versatile contract research organization that delivers a wide array of research and testing services both domestically and internationally. The company caters to a broad spectrum of industries, including agriculture, pharmaceuticals, medical devices, and food, among others, by offering specialized services that support the entire lifecycle of product development and maintenance. Vimta Labs places a strong emphasis on quality, safety, and regulatory compliance in delivering its solutions, making it a trusted partner for businesses across various sectors seeking dependable research and testing services.
Products and Services
- Product Discovery/Development: Support services aimed at assisting in the discovery and development of new products across various industries.
- Post Approval/Marketing: Services designed to support products post-approval, including market readiness and compliance checks.
- Preclinical/Early Development/Study: Conducting initial studies and research necessary for the early stages of product development.
- Clinical Research and Development: Comprehensive research and development services that cover the clinical phase, ensuring the efficacy and safety of products.
- Drug Life Cycle Management Support: Offering support throughout the drug life cycle from conception to post-market surveillance.
- Bioanalytical, Analytical: Providing detailed bioanalytical and analytical testing services to analyze the composition and properties of substances.
- Central Lab: State-of-the-art laboratory services that support clinical trials and research projects.
- Genetically Modified Organisms Testing: Specialized testing for GMOs to ensure safety and compliance with regulatory standards.
- Clinical Diagnostics: Diagnostic services that aid in the detection and analysis of clinical conditions.
- Environment Testing: Testing services focused on environmental samples to assess contamination and compliance with environmental standards.
- Preclinical Research and Testing: Essential services for the preclinical phase, focusing on safety and efficacy testing before clinical trials.
- Food Testing and Analytical Development: Specialized testing services for the food industry, ensuring quality and safety of food products.
- EMI/EMC Testing: Electromagnetic interference and compatibility testing services for electrical and electronic devices.
- IND/505(b)(2) Enabling/Studies; IVPT, IVRT, and IVBE Studies: Offering services that assist in the investigational new drug (IND) submission process and in vitro studies for permeation, release, and bioequivalence.
- Dioxins and Furans, Trace Heavy Metals Testing: Specialized testing for detecting dioxins, furans, and trace levels of heavy metals in various samples.
- Label Claims, Radioactive Isotopes, Vitamins and Minerals Testing: Verification tests for label claims and the analysis of radioactive isotopes, vitamins, and minerals.
- Packaging and Shelf Life Testing: Services related to the testing of packaging materials and determining the shelf life of products.
Contact Information
Address: Plot Nos. 141/2 & 142, IDA, Phase II
Phone: 91 40 2726 4141
Website: https://vimta.com
